Follitropin Alfa

Welcome to Dwaey, specifically on Follitropin Alfa page.
This medicine contains important and useful components, as it consists of
Follitropin Alfa is available in the market in concentration.

Generic Name of Follitropin Alfa - Learn More

Follitropin Alfa

Follitropin Alfa Precaution - What You Need to Know

Before starting Follitropin Alfa, patients should consult with their healthcare provider due to the following precautions:

- Ovarian Hyperstimulation Syndrome (OHSS): Follitropin Alfa can lead to OHSS, a potentially life-threatening condition where the ovaries become swollen and painful. Women should be monitored closely, especially during the early stages of treatment. Symptoms of OHSS include abdominal pain, bloating, nausea, and vomiting. Immediate medical attention is necessary if these symptoms occur.
- Multiple Pregnancies: Follitropin Alfa increases the likelihood of multiple pregnancies (twins, triplets, etc.), which can increase the risks for both the mother and the babies. Patients should be informed of the potential for multiple pregnancies and undergo regular monitoring.
- Ovarian Cysts: Patients with ovarian cysts should be carefully evaluated before using Follitropin Alfa, as it may exacerbate existing conditions. Follitropin Alfa should not be used in women with primary ovarian failure or in cases of abnormal uterine bleeding where the cause is unclear.
- Liver and Kidney Disease: Follitropin Alfa should be used with caution in patients with significant liver or kidney disease. Liver and renal function should be assessed before starting therapy, and the response to treatment should be monitored closely.
- Pregnancy: Follitropin Alfa should not be used during pregnancy, as its safety in pregnant women has not been established. It is only used for fertility treatments, and women should avoid pregnancy during treatment.
- Multiple Previous IVF Failures: Women with repeated unsuccessful in vitro fertilization (IVF) attempts should be monitored carefully, as Follitropin Alfa might lead to ovarian overstimulation or other complications in these patients.

Follitropin Alfa Indication - Uses and Benefits

Follitropin Alfa is primarily indicated for the following:

- Female Infertility Treatment: Follitropin Alfa is used for ovarian stimulation in women who are undergoing assisted reproductive technologies (ART) such as in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). It is used to stimulate the ovaries to produce multiple follicles, which increases the chances of egg retrieval.
- Hypogonadotropic Hypogonadism: It is also used in women with hypogonadotropic hypogonadism (a condition where the body does not produce enough gonadotropins) to induce ovulation. This treatment is commonly prescribed for women who do not ovulate due to hormonal imbalances.
- Male Infertility: In certain cases, Follitropin Alfa can be used in men with hypogonadotropic hypogonadism to stimulate the production of sperm and improve fertility.

Follitropin Alfa Contraindications - Important Warnings

Follitropin Alfa should not be used in the following situations:

- Primary Ovarian Failure: Follitropin Alfa should not be used in women who have primary ovarian failure (i.e., when the ovaries do not respond to gonadotropins).
- Pregnancy: It is contraindicated in pregnant women, as its use has not been studied in this population, and the effects on fetal development are not known.
- Uncontrolled Thyroid and Adrenal Disorders: Women with untreated thyroid or adrenal gland disorders should avoid Follitropin Alfa because these conditions may interfere with the effectiveness of the medication or exacerbate complications.
- Abnormal Uterine Bleeding: Follitropin Alfa is contraindicated in patients with abnormal uterine bleeding when the cause is unknown, as it may worsen the underlying condition.
- Ovarian Cysts or Enlarged Ovaries: Women with ovarian cysts or enlarged ovaries should not use Follitropin Alfa, as the medication may worsen these conditions.

Follitropin Alfa Side Effects - What to Expect

The side effects of Follitropin Alfa can range from mild to severe and include:

- Common Side Effects:
- Ovarian Hyperstimulation Syndrome (OHSS): This is one of the most significant risks associated with Follitropin Alfa and can cause symptoms like abdominal pain, nausea, vomiting, and bloating.
- Injection Site Reactions: These include pain, redness, swelling, or bruising at the site where the injection is administered.
- Headache: Some patients report headaches as a common side effect.
- Mood Swings: Hormonal changes may lead to mood changes, including irritability and anxiety.
- Fatigue: Some women may feel more tired than usual during treatment with Follitropin Alfa.

- Severe Side Effects:
- Ovarian Cysts or Enlarged Ovaries: The treatment can cause the ovaries to become excessively enlarged, which can lead to discomfort and other complications.
- Multiple Pregnancies: Follitropin Alfa increases the likelihood of multiple pregnancies, which carry increased risks for both the mother and the babies, such as preterm birth, gestational diabetes, and hypertension.
- Ectopic Pregnancy: There is an increased risk of ectopic pregnancy (when the fertilized egg implants outside the uterus) due to the higher likelihood of multiple pregnancies.
- Ovarian Torsion: Rarely, Follitropin Alfa can cause ovarian torsion, where the ovary twists, leading to severe abdominal pain and potential ovarian damage.

Follitropin Alfa Pregnancy Category ID - Safety Information

5

Follitropin Alfa Mode of Action - How It Works

Follitropin Alfa is a recombinant form of human follicle-stimulating hormone (FSH), a hormone involved in the development of eggs (oocytes) in women and sperm production in men. FSH stimulates the follicles in the ovaries to mature and produce eggs. In women, Follitropin Alfa works by stimulating ovarian follicles to grow and mature, which is necessary for ovulation and successful fertilization. The drug also plays a role in sperm production in men with certain types of infertility. By mimicking natural FSH, Follitropin Alfa helps promote ovarian and follicular development during fertility treatments like in vitro fertilization (IVF) and intrauterine insemination (IUI).

Follitropin Alfa Drug Interactions - What to Avoid

Follitropin Alfa may interact with certain drugs or substances, potentially altering its effects or causing side effects:

- Other Fertility Drugs: Caution is advised when combining Follitropin Alfa with other fertility medications, as it may increase the risk of ovarian hyperstimulation syndrome (OHSS) or other complications related to excessive ovarian stimulation.
- Corticosteroids: If used with corticosteroids, Follitropin Alfa may increase the risk of fluid retention, which can worsen OHSS or lead to other complications such as high blood pressure.
- Thyroid Hormone Therapy: Follitropin Alfa may interact with thyroid hormone therapy, potentially altering the effectiveness of both treatments. Thyroid function should be monitored closely during treatment.
- Anticoagulants: Follitropin Alfa may increase the risk of bleeding in patients who are on anticoagulants, so blood clotting should be monitored regularly.

Follitropin Alfa Adult Dose - Recommended Dosage

For female infertility treatment, the standard dosing regimen is:

- For Ovulation Induction: Follitropin Alfa is typically administered as subcutaneous injections. The usual dose is 75 IU per day, beginning on day 2 or 3 of the menstrual cycle and continuing until an adequate response is achieved (usually 7–14 days). Doses may be adjusted based on the ovarian response as determined by ultrasound or serum estrogen levels.
- For Assisted Reproductive Technology (ART): In patients undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), the typical starting dose is 150 IU per day, and it is adjusted based on ovarian response.

Follitropin Alfa Child Dose - Dosage for Children

Follitropin Alfa is not approved for use in children, as it is primarily used for adult infertility treatment. Its safety and efficacy in pediatric populations have not been established.

As always, patients should consult their healthcare provider for the correct dosing and monitoring when starting Follitropin Alfa to ensure safe and effective use.

Follitropin Alfa Renal Dose - Dosage for Kidney Conditions

Follitropin Alfa has not been specifically studied in patients with renal impairment. Therefore, caution is advised when using Follitropin Alfa in patients with kidney disease. Kidney function should be monitored regularly, and the dose may need to be adjusted accordingly.